Skip to main content

Table 6 Magnitude of effects of SMT and GE intervention on primary and secondary outcomes

From: Effects of a movement control and tactile acuity training in patients with nonspecific chronic low back pain and control impairment – a randomised controlled pilot study

  Median (IQR) t1a Median (IQR) t1b Median (IQR) t2 t1a vs. t1b (ICC) Intragroup comparison t1a vs t2 p (r) Intragroup Δt2-t1a median Intergroup comparison of intragroup Δt2-t1a (p)
BPI Intensity
 SMT 3.50 (1.75–4.13) 3.00 (1.25–5.13) 1.13 (0.50–3.44) 0.85 0.01* (0.63) -1.25 0.26
 GE 3.00 (2.19–4.19) 3.75 (1.50–3.94) 2.00 (1.81–3.00) 0.07 -0.88
BPI Interference
 SMT 1.93 (0.64–3.46) 1.57 (0.39–4.11) 0.36 (0.11–2.21) 0.90 ≤0.001* (0.83) -0.86 0.25
 GE 1.50 (0.89–2.82) 1.43 (0.64–2.39) 0.93 (0.29–2.61) 0.17 -0.50
RMDQ
 SMT 4.50 (2.00–8.75) 6.50 (2.75–10.25) 3.50 (1.00–7.00) 0.89 0.803 0.00 0.64
 GE 5.00 (1.50–6.00) 4.00 (2.00–5.00) 3.00 (2.00–4.75) 0.03* (0.53) -1.00
ODI
 SMT 22.00 (9.50–30.50) 22.00 (13.50–32.00) 11.00 (6.00–26.50) 0.92 0.03* (0.51) -3.00 0.97
 GE 20.00 (12.00–26.67) 17.89 (10.50–22.00) 16.00 (10.50–21.67) 0.03* (0.53) -4.00
SF-36 PC
 SMT 38.62 (32.34–47.65) 38.98 (31.56–48.11) 46.43 (39.83–52.29) 0.91 0.01* (−0.67) +6.47 0.11
 GE 45.47 (37.18–48.20) 45.64 (37.40–52.98) 47.83 (43.70–52.41) 0.15 +3.09
SF-36 MC
 SMT 50.51 (45.07–56.34) 53.51 (37.39–57.11) 55.40 (36.24–59.46) 0.94 0.94 +1.02 0.88
 GE 54.09 (44.11–58.72) 54.20 (47.70–59.23) 52.77 (48.62–58.52) 0.27 +0.66
2PD [mm]
 SMT 64.38 (48.75–76.88) 50.63 (46.88–63.75) 43.13 (35.00–66.56) 0.73 0.002* (0.75) -13.13 0.09
 GE 60.63 (41.88–68.44) 58.75 (43.75–68.13) 53.13 (39.38–66.56) 0.20 -3.13
MCT [number of positive tests]
 SMT 4.00 (3.00–4.25) 4.00 (3.75–4.00) 1.50 (1.00–3.00) 0.85 ≤0.001* (0.86) -2.00 0.05*
 GE 4.00 (3.00–5.00) 4.00 (3.25–5.00) 3.50 (2.00–4.75) 0.05 -1.00
HADS A
 SMT 6.50 (3.00–10.25) 6.00 (2.75–11.00) 4.50 (2.75–9.25) 0.98 0.04* (0.50) -1.00 0.67
 GE 5.50 (2.00–8.75) 4.50 (2.00–8.00) 4.50 (2.00–8.00) 0.10 -1.00
HADS D
 SMT 4.00 (1.00–6.00) 3.00 (1.00–5.25) 2.00 (1.00–5.00) 0.97 0.04* (0.50) 0.00 1.00
 GE 2.50 (1.00–4.50) 2.00 (1.00–4.75) 1.00 (0.25–5.75) 0.09 -1.00  
FABQ Activity
 SMT 12.00 (10.75–15.25) 11.50 (8.75–14.50) 10.50 (6.75–12.00) 0.72 0.02* (0.53) -1.50 0.44
 GE 9.50 (6.25–14.50) 10.50 (5.75–16.00) 10.00 (5.50–14.75) 0.68 -1.50
FABQ Work
 SMT 10.50 (2.00–18.00) 12.50 (3.75–21.25) 9.00 (2.75–19.00) 0.87 0.50 0.00 0.07
 GE 8.50 (2.00–19.25) 10.00 (1.25–15.75) 8.50 (1.25–12.00) 0.02* (0.57) -2.00
  1. A Anxiety, BPI Brief Pain Inventory, D Depression, FABQ Fear Avoidance and Beliefs Questionnaire, GE General exercise programme, HADS Hospital Anxiety and Depression Scale, ICC Intraclass-correlation coefficient, MC Mental component, MCT Movement control tests, ODI Oswestry Disability Index, PC Physical component, RMDQ Roland Morris Disability Questionnaire, SF-36 Short-Form 36, SMT Specific sensorimotor treatment, t1a first measurement point, t1b second measurement point, t2 follow-up measurement, 2PD two-point discrimination